[1] 张传猛,万崇华,杨铮,等.冠心病患者报告结局量表信度分析[J].中国全科医学,2019,22(11):1350-1354. [2] IWASHIMA Y,ISHIMITSU T.How should we define appropriate patients for percutaneous transluminal renal angioplasty treatment?[J].Hypertens Res,2020,43(10):1015-1027. [3] 曹舸,余惠,范景秀,等.急性心肌梗死患者体内miR-208表达与心肌损伤、血小板活化的相关性分析[J].疑难病杂志,2019,18(1):23-26. [4] KWON Y C,KIM J J,YU J J,et al.Identification of the TIFAB Gene as a susceptibility locus for coronary artery aneurysm in patients with kawasaki disease[J].Pediatric Cardiol,2019,40(3):483-488. [5] 卢红蓉,李海玉,李志更,等.基于现代文献的冠心病中医病因病机概念研究[J].吉林中医药,2018,38(5):497-499. [6] ILARIA C,CANNON C P,EUGENE B,et al.Metabolic syndrome and the risk of adverse cardiovascular events after an acute coronary syndrome[J].Eur J Prev Cardiol,2020,25(8):830-838. [7] 江贵军,吕菁君.血小板活化及其相关免疫反应在脓毒症中的作用[J].中国感染控制杂志,2019,18(3):271-276. [8] 金秀,李屏,曹宏玲.全程护理模式对冠心病合并糖尿病患者PCI术后生活质量及心血管不良事件的影响[J].海南医学,2019,30(5):675-677. [9] 熊家瑞,黎明江,黄亚敏,等.冠心病患者PCI术后支架内再狭窄的临床特点及危险因素分析[J].疑难病杂志,2019,18(8):760-764. [10] 李博倩,于强.PAC-1和CD62p活化程度与ACS患者冠状动脉狭窄程度的相关性研究[J].重庆医学,2020,49(2):205-208.
2022, Vol. 39 
